World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02235935
Date of registration: 08/09/2014
Prospective Registration: No
Primary sponsor: Assaf-Harofeh Medical Center
Public title: The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy
Scientific title: The Effect of Hyperbaric Chamber Treatment on Patients With Diabetic Retinopathy
Date of first enrolment: September 2014
Target sample size: 40
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02235935
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Israel
Contacts
Name:     Rubinstein, MD
Address: 
Telephone: 0097289779358
Email:
Affiliation: 
Name:     Shai Efrati
Address: 
Telephone:
Email:
Affiliation:  Assaf Harofe MC
Key inclusion & exclusion criteria

Inclusion Criteria:

Inclusion criteria:

1. Patients between ages 18-90 with Diabetes type I or II and diabetic retinopathy who
are scheduled for hyperbaric treatment for other indications than DR.

2. Patients who signed an informed consent form and agree to undergo an ophthalmic
physical examination, Fundus photography and OCT prior to hyperbaric treatment and
oCT exam following every 10 treatments in hyperbaric chamber. Total number of
hyperbaric treatments will be conducted according to the main indication for which
they have been assigned this treatment.

Exclusion Criteria:

1. Patients with Carotid stenosis of more than 70%

2. Anemia of < 10mg/Dl

3. Patients with chest X ray pathology which cannot be admitted to hyperbaric chamber
treatment.

4. Patients with claustrophobia or that cannot decompress properly.

5. Patients with any malignant disease

6. Patients with inability to sign informed consent

Decompression treatment will last 90 minutes in 2 atmospheres pressure with 100% oxygen.

-



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Does Hyperbaric Chaber Treatment Improve Diabetic Retinopathy
Intervention(s)
Primary Outcome(s)
OCT results [Time Frame: 1 month]
Secondary Outcome(s)
Visual Acuity [Time Frame: 1 month]
Secondary ID(s)
112/14
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history